Saklatvala
George Saklatvala, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20140071164 | CONTROLLING AN AUGMENTED REALITY OBJECT - Techniques for controlling an augmented reality object are described in various implementations. In one example implementation, a method may include receiving an initialization image captured by an image capture device, the initialization image depicting a background and being free of foreground objects positioned between the background and the image capture device. The method may also include receiving a plurality of subsequent images captured by the image capture device over a period of time, the plurality of subsequent images depicting the background and a foreground object, the foreground object being positioned between the background and the image capture device. The method may also include comparing the initialization image to the plurality of subsequent images to determine positioning of the foreground object over the period of time. The method may also include controlling an augmented reality object based on the positioning of the foreground object over the period of time. | 03-13-2014 |
Robert Saklatvala, Stevenage GB
Patent application number | Description | Published |
---|---|---|
20080275020 | PHARMACEUTICAL FORMULATION - The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability. | 11-06-2008 |
Robert Saklatvala, Rahway, NJ US
Patent application number | Description | Published |
---|---|---|
20140093564 | PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH SIMVASTATIN - The present invention is directed to novel pharmaceutical compositions comprising fixed dose combinations of a dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor), or a pharmaceutically acceptable salt thereof, and simvastatin, or pharmaceutically acceptable salt thereof, methods of preparing such pharmaceutical compositions, and methods of treating Type 2 diabetes and hypercholesterolemia with such pharmaceutical compositions. In particular, the invention is directed to pharmaceutical compositions comprising fixed-dose combinations of sitagliptin phosphate and simvastatin. | 04-03-2014 |